Colony Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $28.9M | Sell |
185,877
-3,448
| -2% | -$569K | 0.43% | 56 |
|
|
2023
Q2 | $31.3M | Sell |
189,325
-4,118
| -2% | -$665K | 0.44% | 52 |
|
|
2023
Q1 | $30M | Sell |
193,443
-43,375
| -18% | -$7M | 0.44% | 49 |
|
|
2022
Q4 | $41.8M | Buy |
236,818
+15,962
| +7% | +$2.76M | 0.59% | 40 |
|
|
2022
Q3 | $36.1M | Sell |
220,856
-247
| -0.1% | -$41.8K | 0.64% | 33 |
|
|
2022
Q2 | $39.2M | Buy |
221,103
+23,832
| +12% | +$4.25M | 0.68% | 30 |
|
|
2022
Q1 | $35M | Buy |
197,271
+94,106
| +91% | +$16M | 0.52% | 44 |
|
|
2021
Q4 | $17.6M | Sell |
103,165
-235
| -0.2% | -$38.5K | 0.31% | 78 |
|
|
2021
Q3 | $16.7M | Buy |
103,400
+313
| +0.3% | +$53.4K | 0.32% | 77 |
|
|
2021
Q2 | $17M | Sell |
103,087
-4,537
| -4% | -$751K | 0.34% | 82 |
|
|
2021
Q1 | $17.7M | Buy |
107,624
+5,122
| +5% | +$829K | 0.37% | 71 |
|
|
2020
Q4 | $16.1M | Buy |
102,502
+19,186
| +23% | +$2.83M | 0.37% | 71 |
|
|
2020
Q3 | $12.4M | Buy |
83,316
+18
| +0% | +$2.66K | 0.32% | 75 |
|
|
2020
Q2 | $11.7M | Sell |
83,298
-19,603
| -19% | -$2.86M | 0.34% | 73 |
|
|
2020
Q1 | $13.5M | Buy |
102,901
+2,580
| +3% | +$366K | 0.44% | 58 |
|
|
2019
Q4 | $14.6M | Buy |
100,321
+24,160
| +32% | +$3.28M | 0.37% | 75 |
|
|
2019
Q3 | $9.85M | Sell |
76,161
-2,099
| -3% | -$277K | 0.31% | 91 |
|
|
2019
Q2 | $10.9M | Buy |
78,260
+17,797
| +29% | +$2.46M | 0.35% | 82 |
|
|
2019
Q1 | $8.45M | Buy |
60,463
+14,462
| +31% | +$1.94M | 0.35% | 79 |
|
|
2018
Q4 | $5.94M | Buy |
46,001
+218
| +0.5% | +$30.4K | 0.29% | 95 |
|
|
2018
Q3 | $6.33M | Buy |
45,783
+250
| +0.5% | +$33.2K | 0.32% | 82 |
|
|
2018
Q2 | $5.53M | Sell |
45,533
-2,372
| -5% | -$296K | 0.29% | 94 |
|
|
2018
Q1 | $6.14M | Buy |
47,905
+14,781
| +45% | +$2M | 0.33% | 87 |
|
|
2017
Q4 | $4.63M | Buy |
33,124
+4,187
| +14% | +$583K | 0.29% | 85 |
|
|
2017
Q3 | $3.76M | Sell |
28,937
-1,449
| -5% | -$192K | 0.26% | 86 |
|
|
2017
Q2 | $4.02M | Buy |
30,386
+9,206
| +43% | +$1.17M | 0.29% | 85 |
|
|
2017
Q1 | $2.64M | Buy |
21,180
+2,920
| +16% | +$349K | 0.25% | 90 |
|
|
2016
Q4 | $2.1M | Buy |
18,260
+1,978
| +12% | +$228K | 0.23% | 109 |
|
|
2016
Q3 | $1.92M | Buy |
16,282
+480
| +3% | +$58.2K | 0.21% | 102 |
|
|
2016
Q2 | $1.92M | Sell |
15,802
-3,317
| -17% | -$377K | 0.21% | 104 |
|
|
2016
Q1 | $2.07M | Sell |
19,119
-8,006
| -30% | -$829K | 0.24% | 95 |
|
|
2015
Q4 | $2.79M | Buy |
27,125
+716
| +3% | +$72K | 0.25% | 86 |
|
|
2015
Q3 | $2.46M | Buy |
26,409
+963
| +4% | +$93.2K | 0.29% | 78 |
|
|
2015
Q2 | $2.48M | Buy |
25,446
+11,387
| +81% | +$1.14M | 0.26% | 82 |
|
|
2015
Q1 | $1.41M | Sell |
14,059
-25,648
| -65% | -$2.61M | 0.16% | 123 |
|
|
2014
Q4 | $4.15M | Buy |
39,707
+25,727
| +184% | +$2.71M | 0.43% | 61 |
|
|
2014
Q3 | $1.49M | Buy |
13,980
+11,962
| +593% | +$1.24M | 0.17% | 123 |
|
|
2014
Q2 | $211K | Sell |
2,018
-50
| -2% | -$5.05K | 0.03% | 208 |
|
|
2014
Q1 | $203K | Buy |
2,068
+500
| +32% | +$46.4K | 0.03% | 208 |
|
|
2013
Q4 | $144K | Buy |
+1,568
| New | +$145K | 0.02% | 235 |
|
Other funds holding JNJ
Colony Group's JNJ Position: Q3 2023 in Review
Colony Group reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q3 2023, selling an estimated $569K and leaving 185,877 shares worth $28.9M. The position accounts for 0.43% of the portfolio, ranked #56.
Colony Group first reported a position in JNJ in Q4 2013 and has held it in 40 quarters since. The position peaked at $41.8M in Q4 2022. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.
- Colony Group held 185,877 shares of Johnson & Johnson worth $28.9M as of Q3 2023.
- Colony Group sold 3,448 Johnson & Johnson shares in Q3 2023, an estimated $569K.
- Johnson & Johnson made up 0.43% of Colony Group's portfolio in Q3 2023, its #56 holding.
- Colony Group first reported a position in Johnson & Johnson in Q4 2013 and has held it in 40 quarters since.
- Colony Group's Johnson & Johnson position peaked at $41.8M in Q4 2022.
- 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.
Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.